Sex-based epidemiological and immunovirological characteristics of people living with HIV in current follow-up at a tertiary hospital: a comparative retrospective study, Catalonia, Spain, 1982 to 2020.


Journal

Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin
ISSN: 1560-7917
Titre abrégé: Euro Surveill
Pays: Sweden
ID NLM: 100887452

Informations de publication

Date de publication:
03 2023
Historique:
entrez: 9 3 2023
pubmed: 10 3 2023
medline: 14 3 2023
Statut: ppublish

Résumé

BackgroundEpidemiological and immunovirological features of people living with HIV (PLWH) can vary by sex.AimTo investigate, particularly according to sex, characteristics of PLWH who consulted a tertiary hospital in Barcelona, Spain, in 1982-2020.MethodsPLWH, still in active follow-up in 2020 were retrospectively analysed by sex, age at diagnosis, age at data extraction (December 2020), birth place, CD4+ cell counts, and virological failure.ResultsIn total, 5,377 PLWH (comprising 828 women; 15%) were included. HIV diagnoses in women appeared to decrease from the 1990s, representing 7.4% (61/828) of new diagnoses in 2015-2020. From 1997, proportions of new HIV diagnoses from patients born in Latin America seemed to increase; moreover, for women born outside of Spain, the median age at diagnosis appeared to become younger than for those born in Spain, with significant differences observed in 2005-2009 and 2010-2014 (31 vs 39 years (p = 0.001), and 32 vs 42 years (p < 0.001) respectively), but not in 2015-2020 (35 vs 42 years; p = 0.254). Among women, proportions of late diagnoses (CD4+ cells/mm3 < 350) were higher than men (significantly in 2015-2020: 62% (32/52) vs 46% (300/656); p = 0.030). Initially, virological failure rates were higher in women than men, but they were similar in 2015-2020 (12% (6/52) vs 8% (55/659); p = 0.431). Women ≥ 50 years old represented 68% (564/828) of women actively followed up in 2020.ConclusionsWomen still have higher rates of late HIV diagnoses than men. Among currently-followed-up women, ≥ 50 year-olds, who need age-adapted care represent a high percentage. Stratifying PLWH by sex matters for HIV prevention and control interventions.

Identifiants

pubmed: 36892474
doi: 10.2807/1560-7917.ES.2023.28.10.2200317
pmc: PMC9999459
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Références

Enferm Infecc Microbiol Clin (Engl Ed). 2021 Oct;39(8):372-382
pubmed: 34373227
Open Forum Infect Dis. 2019 Feb 12;6(2):ofz022
pubmed: 30793009
Euro Surveill. 2021 Nov;26(47):
pubmed: 34823642
Clin Infect Dis. 2020 Sep 12;71(6):1379-1389
pubmed: 31606734
N Engl J Med. 1998 Dec 24;339(26):1897-904
pubmed: 9862946
Enferm Infecc Microbiol Clin. 2011 Feb;29(2):144-51
pubmed: 21334780
Lancet Public Health. 2017 Jan;2(1):e35-e46
pubmed: 29249478
PLoS One. 2020 Dec 23;15(12):e0242710
pubmed: 33362248
J Antimicrob Chemother. 2018 Aug 1;73(8):2177-2185
pubmed: 29722811
J Int AIDS Soc. 2013 May 09;16:18560
pubmed: 23663441
Epidemiol Infect. 2017 Jun;145(8):1670-1681
pubmed: 28270252
Curr HIV/AIDS Rep. 2011 Dec;8(4):277-87
pubmed: 21989672
Curr Med Res Opin. 2016 Dec;32(12):2039-2046
pubmed: 27552553
Clin Infect Dis. 2015 Jun 15;60(12):1852-9
pubmed: 25761868
J Acquir Immune Defic Syndr. 2009 Nov 1;52(3):336-41
pubmed: 19654551
Euro Surveill. 2019 Nov;24(48):
pubmed: 31796153
Curr HIV/AIDS Rep. 2018 Apr;15(2):136-146
pubmed: 29504062
HIV Med. 2018 Feb;19(2):167-173
pubmed: 29159861
Medicine (Baltimore). 2021 Jul 2;100(26):e26507
pubmed: 34190180
Lancet. 1998 Nov 7;352(9139):1510-4
pubmed: 9820299
Clin Infect Dis. 2002 Aug 1;35(3):313-22
pubmed: 12115098
AIDS Patient Care STDS. 2012 Aug;26(8):444-53
pubmed: 22734949
J Acquir Immune Defic Syndr. 2003 Apr 1;32(4):452-61
pubmed: 12640206

Auteurs

Sara Toyos (S)

Hospital Verge de la Cinta, Tortosa, University of Barcelona, Barcelona, Spain.

Leire Berrocal (L)

HIV Unit, Infectious Diseases Service, Hospital Clínic, Barcelona, Spain, Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), University of Barcelona, Barcelona, Spain.

Ana González-Cordón (A)

HIV Unit, Infectious Diseases Service, Hospital Clínic, Barcelona, Spain, Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), University of Barcelona, Barcelona, Spain.

Alexy Inciarte (A)

HIV Unit, Infectious Diseases Service, Hospital Clínic, Barcelona, Spain, Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), University of Barcelona, Barcelona, Spain.

Lorena de la Mora (L)

HIV Unit, Infectious Diseases Service, Hospital Clínic, Barcelona, Spain, Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), University of Barcelona, Barcelona, Spain.

María Martínez-Rebollar (M)

HIV Unit, Infectious Diseases Service, Hospital Clínic, Barcelona, Spain, Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), University of Barcelona, Barcelona, Spain.

Montserrat Laguno (M)

HIV Unit, Infectious Diseases Service, Hospital Clínic, Barcelona, Spain, Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), University of Barcelona, Barcelona, Spain.
CIBER de Enfermedades Infecciosas (CIBERINFEC), Instituto de Salud Carlos III, Madrid, Spain.

Emma Fernández (E)

HIV Unit, Infectious Diseases Service, Hospital Clínic, Barcelona, Spain, Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), University of Barcelona, Barcelona, Spain.

Juan Ambrosioni (J)

HIV Unit, Infectious Diseases Service, Hospital Clínic, Barcelona, Spain, Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), University of Barcelona, Barcelona, Spain.
CIBER de Enfermedades Infecciosas (CIBERINFEC), Instituto de Salud Carlos III, Madrid, Spain.

Iván Chivite (I)

HIV Unit, Infectious Diseases Service, Hospital Clínic, Barcelona, Spain, Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), University of Barcelona, Barcelona, Spain.

Elisa de Lazzari (E)

HIV Unit, Infectious Diseases Service, Hospital Clínic, Barcelona, Spain, Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), University of Barcelona, Barcelona, Spain.

José Luis Blanco (JL)

HIV Unit, Infectious Diseases Service, Hospital Clínic, Barcelona, Spain, Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), University of Barcelona, Barcelona, Spain.
CIBER de Enfermedades Infecciosas (CIBERINFEC), Instituto de Salud Carlos III, Madrid, Spain.

Esteban Martínez (E)

HIV Unit, Infectious Diseases Service, Hospital Clínic, Barcelona, Spain, Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), University of Barcelona, Barcelona, Spain.
CIBER de Enfermedades Infecciosas (CIBERINFEC), Instituto de Salud Carlos III, Madrid, Spain.

José M Miró (JM)

HIV Unit, Infectious Diseases Service, Hospital Clínic, Barcelona, Spain, Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), University of Barcelona, Barcelona, Spain.
CIBER de Enfermedades Infecciosas (CIBERINFEC), Instituto de Salud Carlos III, Madrid, Spain.

Josep Mallolas (J)

HIV Unit, Infectious Diseases Service, Hospital Clínic, Barcelona, Spain, Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), University of Barcelona, Barcelona, Spain.
CIBER de Enfermedades Infecciosas (CIBERINFEC), Instituto de Salud Carlos III, Madrid, Spain.

Berta Torres (B)

HIV Unit, Infectious Diseases Service, Hospital Clínic, Barcelona, Spain, Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), University of Barcelona, Barcelona, Spain.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH